Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape
Authors:
- Samik UpadhayaSUSamik Upadhaya
- Svetoslav T. NeftelinovSNSvetoslav T. Neftelinov
- Jeffrey HodgeJHJeffrey Hodge
- Jay CampbellJCJay Campbell
Top Cited Papers
- 10 February 2022
- journal article
- news
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 21 (7) , 482-483